Cancer Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1081651, encodeId=0b391081651bf, content=有幸成为这个期刊的reviewer，大家有什么问题可以咨询我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=50, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf05252569, createdName=sci中中中, createdTime=Sat Dec 18 22:29:56 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224635, encodeId=6e1e12246359b, content=2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗<a href='/topic/show?id=435a10454209' target=_blank style='color:#2F92EE;'>#二审时间#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=23, topicName=null, topicId=null, topicList=[TopicDto(id=104542, encryptionId=435a10454209, topicName=二审时间)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Jun 05 22:59:19 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011351, encodeId=d1e4101135150, content=同志们，2021年的under review 平均时长要多久呀？真的等不下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=澈澈, createdTime=Wed Aug 25 14:11:30 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200952, encodeId=a58512009520a, content=偏重的研究方向：肿瘤;预后;临床 经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=ms5000001742215301, createdTime=Wed Mar 09 17:16:37 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093405, encodeId=cc3c2093405c8, content=偏重的研究方向：不知道 经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70601612109, createdName=zhouj2881, createdTime=Wed Oct 12 16:04:17 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008270, encodeId=6c3a10082e0a0, content=偏重的研究方向：肿瘤 经验分享：pending editor assignment20天了这个是找不到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6495327174, createdName=148bf9cam55暂无昵称, createdTime=Mon Aug 16 10:41:15 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589719, encodeId=5a05589e1940, content=大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, beContent=wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ah6TsnTicIedAahqYyu4Vaz8AYx4BFqtrbafZUbkeYavADIrrBAGT3u6tn2YT6YicbtgnxwcT9sF0mCUKNcTKSiaw/132, createdBy=912e5276906, createdName=木子孑孑, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196925, encodeId=734611969258d, content=偏重的研究方向：肺癌;免疫;临床 经验分享：2021.2.17提交，3天后Awaiting AE Assignment， 2021.2.24 Pending Editor Assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07fc2427886, createdName=123ad51fm20暂无昵称, createdTime=Thu Feb 24 18:47:12 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917027, encodeId=4c0291e02704, content=这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f12441676, createdName=123d78aam27暂无昵称, createdTime=Fri Jan 15 22:32:53 CST 2021, time=2021-01-15, status=1, ipAttribution=)]

2021-12-18 sci中中中

有幸成为这个期刊的reviewer，大家有什么问题可以咨询我

121 50

展开50条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081651, encodeId=0b391081651bf, content=有幸成为这个期刊的reviewer，大家有什么问题可以咨询我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=50, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf05252569, createdName=sci中中中, createdTime=Sat Dec 18 22:29:56 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224635, encodeId=6e1e12246359b, content=2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗<a href='/topic/show?id=435a10454209' target=_blank style='color:#2F92EE;'>#二审时间#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=23, topicName=null, topicId=null, topicList=[TopicDto(id=104542, encryptionId=435a10454209, topicName=二审时间)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Jun 05 22:59:19 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011351, encodeId=d1e4101135150, content=同志们，2021年的under review 平均时长要多久呀？真的等不下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=澈澈, createdTime=Wed Aug 25 14:11:30 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200952, encodeId=a58512009520a, content=偏重的研究方向：肿瘤;预后;临床 经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=ms5000001742215301, createdTime=Wed Mar 09 17:16:37 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093405, encodeId=cc3c2093405c8, content=偏重的研究方向：不知道 经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70601612109, createdName=zhouj2881, createdTime=Wed Oct 12 16:04:17 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008270, encodeId=6c3a10082e0a0, content=偏重的研究方向：肿瘤 经验分享：pending editor assignment20天了这个是找不到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6495327174, createdName=148bf9cam55暂无昵称, createdTime=Mon Aug 16 10:41:15 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589719, encodeId=5a05589e1940, content=大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, beContent=wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ah6TsnTicIedAahqYyu4Vaz8AYx4BFqtrbafZUbkeYavADIrrBAGT3u6tn2YT6YicbtgnxwcT9sF0mCUKNcTKSiaw/132, createdBy=912e5276906, createdName=木子孑孑, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196925, encodeId=734611969258d, content=偏重的研究方向：肺癌;免疫;临床 经验分享：2021.2.17提交，3天后Awaiting AE Assignment， 2021.2.24 Pending Editor Assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07fc2427886, createdName=123ad51fm20暂无昵称, createdTime=Thu Feb 24 18:47:12 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917027, encodeId=4c0291e02704, content=这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f12441676, createdName=123d78aam27暂无昵称, createdTime=Fri Jan 15 22:32:53 CST 2021, time=2021-01-15, status=1, ipAttribution=)]

2021-09-10 繁芜

我来报喜啦，努力没有白费！
7.26投稿
8.31小修
9.7返修
9.10接收
我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！

105 27

展开27条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081651, encodeId=0b391081651bf, content=有幸成为这个期刊的reviewer，大家有什么问题可以咨询我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=50, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf05252569, createdName=sci中中中, createdTime=Sat Dec 18 22:29:56 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224635, encodeId=6e1e12246359b, content=2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗<a href='/topic/show?id=435a10454209' target=_blank style='color:#2F92EE;'>#二审时间#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=23, topicName=null, topicId=null, topicList=[TopicDto(id=104542, encryptionId=435a10454209, topicName=二审时间)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Jun 05 22:59:19 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011351, encodeId=d1e4101135150, content=同志们，2021年的under review 平均时长要多久呀？真的等不下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=澈澈, createdTime=Wed Aug 25 14:11:30 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200952, encodeId=a58512009520a, content=偏重的研究方向：肿瘤;预后;临床 经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=ms5000001742215301, createdTime=Wed Mar 09 17:16:37 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093405, encodeId=cc3c2093405c8, content=偏重的研究方向：不知道 经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70601612109, createdName=zhouj2881, createdTime=Wed Oct 12 16:04:17 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008270, encodeId=6c3a10082e0a0, content=偏重的研究方向：肿瘤 经验分享：pending editor assignment20天了这个是找不到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6495327174, createdName=148bf9cam55暂无昵称, createdTime=Mon Aug 16 10:41:15 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589719, encodeId=5a05589e1940, content=大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, beContent=wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ah6TsnTicIedAahqYyu4Vaz8AYx4BFqtrbafZUbkeYavADIrrBAGT3u6tn2YT6YicbtgnxwcT9sF0mCUKNcTKSiaw/132, createdBy=912e5276906, createdName=木子孑孑, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196925, encodeId=734611969258d, content=偏重的研究方向：肺癌;免疫;临床 经验分享：2021.2.17提交，3天后Awaiting AE Assignment， 2021.2.24 Pending Editor Assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07fc2427886, createdName=123ad51fm20暂无昵称, createdTime=Thu Feb 24 18:47:12 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917027, encodeId=4c0291e02704, content=这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f12441676, createdName=123d78aam27暂无昵称, createdTime=Fri Jan 15 22:32:53 CST 2021, time=2021-01-15, status=1, ipAttribution=)]

2022-06-05 12315a97m77暂无昵称

2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗#二审时间#

66 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081651, encodeId=0b391081651bf, content=有幸成为这个期刊的reviewer，大家有什么问题可以咨询我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=50, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf05252569, createdName=sci中中中, createdTime=Sat Dec 18 22:29:56 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224635, encodeId=6e1e12246359b, content=2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗<a href='/topic/show?id=435a10454209' target=_blank style='color:#2F92EE;'>#二审时间#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=23, topicName=null, topicId=null, topicList=[TopicDto(id=104542, encryptionId=435a10454209, topicName=二审时间)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Jun 05 22:59:19 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011351, encodeId=d1e4101135150, content=同志们，2021年的under review 平均时长要多久呀？真的等不下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=澈澈, createdTime=Wed Aug 25 14:11:30 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200952, encodeId=a58512009520a, content=偏重的研究方向：肿瘤;预后;临床 经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=ms5000001742215301, createdTime=Wed Mar 09 17:16:37 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093405, encodeId=cc3c2093405c8, content=偏重的研究方向：不知道 经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70601612109, createdName=zhouj2881, createdTime=Wed Oct 12 16:04:17 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008270, encodeId=6c3a10082e0a0, content=偏重的研究方向：肿瘤 经验分享：pending editor assignment20天了这个是找不到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6495327174, createdName=148bf9cam55暂无昵称, createdTime=Mon Aug 16 10:41:15 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589719, encodeId=5a05589e1940, content=大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, beContent=wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ah6TsnTicIedAahqYyu4Vaz8AYx4BFqtrbafZUbkeYavADIrrBAGT3u6tn2YT6YicbtgnxwcT9sF0mCUKNcTKSiaw/132, createdBy=912e5276906, createdName=木子孑孑, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196925, encodeId=734611969258d, content=偏重的研究方向：肺癌;免疫;临床 经验分享：2021.2.17提交，3天后Awaiting AE Assignment， 2021.2.24 Pending Editor Assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07fc2427886, createdName=123ad51fm20暂无昵称, createdTime=Thu Feb 24 18:47:12 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917027, encodeId=4c0291e02704, content=这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f12441676, createdName=123d78aam27暂无昵称, createdTime=Fri Jan 15 22:32:53 CST 2021, time=2021-01-15, status=1, ipAttribution=)]

2021-08-25 澈澈

同志们，2021年的under review 平均时长要多久呀？真的等不下去了

66 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081651, encodeId=0b391081651bf, content=有幸成为这个期刊的reviewer，大家有什么问题可以咨询我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=50, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf05252569, createdName=sci中中中, createdTime=Sat Dec 18 22:29:56 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224635, encodeId=6e1e12246359b, content=2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗<a href='/topic/show?id=435a10454209' target=_blank style='color:#2F92EE;'>#二审时间#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=23, topicName=null, topicId=null, topicList=[TopicDto(id=104542, encryptionId=435a10454209, topicName=二审时间)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Jun 05 22:59:19 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011351, encodeId=d1e4101135150, content=同志们，2021年的under review 平均时长要多久呀？真的等不下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=澈澈, createdTime=Wed Aug 25 14:11:30 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200952, encodeId=a58512009520a, content=偏重的研究方向：肿瘤;预后;临床 经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=ms5000001742215301, createdTime=Wed Mar 09 17:16:37 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093405, encodeId=cc3c2093405c8, content=偏重的研究方向：不知道 经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70601612109, createdName=zhouj2881, createdTime=Wed Oct 12 16:04:17 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008270, encodeId=6c3a10082e0a0, content=偏重的研究方向：肿瘤 经验分享：pending editor assignment20天了这个是找不到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6495327174, createdName=148bf9cam55暂无昵称, createdTime=Mon Aug 16 10:41:15 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589719, encodeId=5a05589e1940, content=大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, beContent=wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ah6TsnTicIedAahqYyu4Vaz8AYx4BFqtrbafZUbkeYavADIrrBAGT3u6tn2YT6YicbtgnxwcT9sF0mCUKNcTKSiaw/132, createdBy=912e5276906, createdName=木子孑孑, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196925, encodeId=734611969258d, content=偏重的研究方向：肺癌;免疫;临床 经验分享：2021.2.17提交，3天后Awaiting AE Assignment， 2021.2.24 Pending Editor Assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07fc2427886, createdName=123ad51fm20暂无昵称, createdTime=Thu Feb 24 18:47:12 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917027, encodeId=4c0291e02704, content=这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f12441676, createdName=123d78aam27暂无昵称, createdTime=Fri Jan 15 22:32:53 CST 2021, time=2021-01-15, status=1, ipAttribution=)]

2022-03-09 ms5000001742215301

偏重的研究方向：肿瘤;预后;临床
经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。

64 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081651, encodeId=0b391081651bf, content=有幸成为这个期刊的reviewer，大家有什么问题可以咨询我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=50, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf05252569, createdName=sci中中中, createdTime=Sat Dec 18 22:29:56 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224635, encodeId=6e1e12246359b, content=2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗<a href='/topic/show?id=435a10454209' target=_blank style='color:#2F92EE;'>#二审时间#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=23, topicName=null, topicId=null, topicList=[TopicDto(id=104542, encryptionId=435a10454209, topicName=二审时间)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Jun 05 22:59:19 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011351, encodeId=d1e4101135150, content=同志们，2021年的under review 平均时长要多久呀？真的等不下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=澈澈, createdTime=Wed Aug 25 14:11:30 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200952, encodeId=a58512009520a, content=偏重的研究方向：肿瘤;预后;临床 经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=ms5000001742215301, createdTime=Wed Mar 09 17:16:37 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093405, encodeId=cc3c2093405c8, content=偏重的研究方向：不知道 经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70601612109, createdName=zhouj2881, createdTime=Wed Oct 12 16:04:17 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008270, encodeId=6c3a10082e0a0, content=偏重的研究方向：肿瘤 经验分享：pending editor assignment20天了这个是找不到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6495327174, createdName=148bf9cam55暂无昵称, createdTime=Mon Aug 16 10:41:15 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589719, encodeId=5a05589e1940, content=大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, beContent=wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ah6TsnTicIedAahqYyu4Vaz8AYx4BFqtrbafZUbkeYavADIrrBAGT3u6tn2YT6YicbtgnxwcT9sF0mCUKNcTKSiaw/132, createdBy=912e5276906, createdName=木子孑孑, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196925, encodeId=734611969258d, content=偏重的研究方向：肺癌;免疫;临床 经验分享：2021.2.17提交，3天后Awaiting AE Assignment， 2021.2.24 Pending Editor Assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07fc2427886, createdName=123ad51fm20暂无昵称, createdTime=Thu Feb 24 18:47:12 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917027, encodeId=4c0291e02704, content=这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f12441676, createdName=123d78aam27暂无昵称, createdTime=Fri Jan 15 22:32:53 CST 2021, time=2021-01-15, status=1, ipAttribution=)]

2022-10-12 zhouj2881

偏重的研究方向：不知道
经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦.

66 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081651, encodeId=0b391081651bf, content=有幸成为这个期刊的reviewer，大家有什么问题可以咨询我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=50, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf05252569, createdName=sci中中中, createdTime=Sat Dec 18 22:29:56 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224635, encodeId=6e1e12246359b, content=2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗<a href='/topic/show?id=435a10454209' target=_blank style='color:#2F92EE;'>#二审时间#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=23, topicName=null, topicId=null, topicList=[TopicDto(id=104542, encryptionId=435a10454209, topicName=二审时间)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Jun 05 22:59:19 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011351, encodeId=d1e4101135150, content=同志们，2021年的under review 平均时长要多久呀？真的等不下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=澈澈, createdTime=Wed Aug 25 14:11:30 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200952, encodeId=a58512009520a, content=偏重的研究方向：肿瘤;预后;临床 经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=ms5000001742215301, createdTime=Wed Mar 09 17:16:37 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093405, encodeId=cc3c2093405c8, content=偏重的研究方向：不知道 经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70601612109, createdName=zhouj2881, createdTime=Wed Oct 12 16:04:17 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008270, encodeId=6c3a10082e0a0, content=偏重的研究方向：肿瘤 经验分享：pending editor assignment20天了这个是找不到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6495327174, createdName=148bf9cam55暂无昵称, createdTime=Mon Aug 16 10:41:15 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589719, encodeId=5a05589e1940, content=大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, beContent=wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ah6TsnTicIedAahqYyu4Vaz8AYx4BFqtrbafZUbkeYavADIrrBAGT3u6tn2YT6YicbtgnxwcT9sF0mCUKNcTKSiaw/132, createdBy=912e5276906, createdName=木子孑孑, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196925, encodeId=734611969258d, content=偏重的研究方向：肺癌;免疫;临床 经验分享：2021.2.17提交，3天后Awaiting AE Assignment， 2021.2.24 Pending Editor Assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07fc2427886, createdName=123ad51fm20暂无昵称, createdTime=Thu Feb 24 18:47:12 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917027, encodeId=4c0291e02704, content=这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f12441676, createdName=123d78aam27暂无昵称, createdTime=Fri Jan 15 22:32:53 CST 2021, time=2021-01-15, status=1, ipAttribution=)]

2021-08-16 148bf9cam55暂无昵称

偏重的研究方向：肿瘤
经验分享：pending editor assignment20天了这个是找不到编辑吗

71 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081651, encodeId=0b391081651bf, content=有幸成为这个期刊的reviewer，大家有什么问题可以咨询我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=50, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf05252569, createdName=sci中中中, createdTime=Sat Dec 18 22:29:56 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224635, encodeId=6e1e12246359b, content=2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗<a href='/topic/show?id=435a10454209' target=_blank style='color:#2F92EE;'>#二审时间#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=23, topicName=null, topicId=null, topicList=[TopicDto(id=104542, encryptionId=435a10454209, topicName=二审时间)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Jun 05 22:59:19 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011351, encodeId=d1e4101135150, content=同志们，2021年的under review 平均时长要多久呀？真的等不下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=澈澈, createdTime=Wed Aug 25 14:11:30 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200952, encodeId=a58512009520a, content=偏重的研究方向：肿瘤;预后;临床 经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=ms5000001742215301, createdTime=Wed Mar 09 17:16:37 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093405, encodeId=cc3c2093405c8, content=偏重的研究方向：不知道 经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70601612109, createdName=zhouj2881, createdTime=Wed Oct 12 16:04:17 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008270, encodeId=6c3a10082e0a0, content=偏重的研究方向：肿瘤 经验分享：pending editor assignment20天了这个是找不到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6495327174, createdName=148bf9cam55暂无昵称, createdTime=Mon Aug 16 10:41:15 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589719, encodeId=5a05589e1940, content=大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, beContent=wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ah6TsnTicIedAahqYyu4Vaz8AYx4BFqtrbafZUbkeYavADIrrBAGT3u6tn2YT6YicbtgnxwcT9sF0mCUKNcTKSiaw/132, createdBy=912e5276906, createdName=木子孑孑, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196925, encodeId=734611969258d, content=偏重的研究方向：肺癌;免疫;临床 经验分享：2021.2.17提交，3天后Awaiting AE Assignment， 2021.2.24 Pending Editor Assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07fc2427886, createdName=123ad51fm20暂无昵称, createdTime=Thu Feb 24 18:47:12 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917027, encodeId=4c0291e02704, content=这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f12441676, createdName=123d78aam27暂无昵称, createdTime=Fri Jan 15 22:32:53 CST 2021, time=2021-01-15, status=1, ipAttribution=)]

2020-04-26 木子孑孑

大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表:
2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。

wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。

159 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081651, encodeId=0b391081651bf, content=有幸成为这个期刊的reviewer，大家有什么问题可以咨询我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=50, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf05252569, createdName=sci中中中, createdTime=Sat Dec 18 22:29:56 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224635, encodeId=6e1e12246359b, content=2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗<a href='/topic/show?id=435a10454209' target=_blank style='color:#2F92EE;'>#二审时间#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=23, topicName=null, topicId=null, topicList=[TopicDto(id=104542, encryptionId=435a10454209, topicName=二审时间)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Jun 05 22:59:19 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011351, encodeId=d1e4101135150, content=同志们，2021年的under review 平均时长要多久呀？真的等不下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=澈澈, createdTime=Wed Aug 25 14:11:30 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200952, encodeId=a58512009520a, content=偏重的研究方向：肿瘤;预后;临床 经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=ms5000001742215301, createdTime=Wed Mar 09 17:16:37 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093405, encodeId=cc3c2093405c8, content=偏重的研究方向：不知道 经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70601612109, createdName=zhouj2881, createdTime=Wed Oct 12 16:04:17 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008270, encodeId=6c3a10082e0a0, content=偏重的研究方向：肿瘤 经验分享：pending editor assignment20天了这个是找不到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6495327174, createdName=148bf9cam55暂无昵称, createdTime=Mon Aug 16 10:41:15 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589719, encodeId=5a05589e1940, content=大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, beContent=wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ah6TsnTicIedAahqYyu4Vaz8AYx4BFqtrbafZUbkeYavADIrrBAGT3u6tn2YT6YicbtgnxwcT9sF0mCUKNcTKSiaw/132, createdBy=912e5276906, createdName=木子孑孑, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196925, encodeId=734611969258d, content=偏重的研究方向：肺癌;免疫;临床 经验分享：2021.2.17提交，3天后Awaiting AE Assignment， 2021.2.24 Pending Editor Assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07fc2427886, createdName=123ad51fm20暂无昵称, createdTime=Thu Feb 24 18:47:12 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917027, encodeId=4c0291e02704, content=这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f12441676, createdName=123d78aam27暂无昵称, createdTime=Fri Jan 15 22:32:53 CST 2021, time=2021-01-15, status=1, ipAttribution=)]

2022-02-24 123ad51fm20暂无昵称

偏重的研究方向：肺癌;免疫;临床
经验分享：2021.2.17提交，3天后Awaiting AE Assignment，
2021.2.24 Pending Editor Assignment

60 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=1081651, encodeId=0b391081651bf, content=有幸成为这个期刊的reviewer，大家有什么问题可以咨询我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=50, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edf05252569, createdName=sci中中中, createdTime=Sat Dec 18 22:29:56 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224635, encodeId=6e1e12246359b, content=2022.3.28递交的R1，到现在还有under review,有人遇到二审这么久的吗，要写信给编辑吗<a href='/topic/show?id=435a10454209' target=_blank style='color:#2F92EE;'>#二审时间#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=23, topicName=null, topicId=null, topicList=[TopicDto(id=104542, encryptionId=435a10454209, topicName=二审时间)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae22381936, createdName=12315a97m77暂无昵称, createdTime=Sun Jun 05 22:59:19 CST 2022, time=2022-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011351, encodeId=d1e4101135150, content=同志们，2021年的under review 平均时长要多久呀？真的等不下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=澈澈, createdTime=Wed Aug 25 14:11:30 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200952, encodeId=a58512009520a, content=偏重的研究方向：肿瘤;预后;临床 经验分享：我的投稿过程如下，希望对大家以后投稿有所帮助： 2021-12-17: Submitted/Undergoing initial checking; 2021-12-27: Under Review; 2022-2-9: Pending Recommendation; 2022-2-9: Pending Decision; 2022-2-9: Major Revision (Due to: 2022-3-9); 2022-3-3: Revision Submitted/Undergoing initial checking; 2022-3-4: Pending Recommendation; 2022-3-7: Pending Decision; 2022-3-8: Accept. 返修有9个意见，审稿人意见都比较中肯，没有故意刁难，认真回答了每一个问题，请教了不少人，修改稿写了27页，结果还是好的。总体来说，这个杂志效率还是可以的，版面费比较贵，毕业生着急的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=ms5000001742215301, createdTime=Wed Mar 09 17:16:37 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093405, encodeId=cc3c2093405c8, content=偏重的研究方向：不知道 经验分享：投稿二十多天了，一直“Pending Editor Assignment”，给发催稿信，回复shortly安排assistant editor，可等了好多天也没见安排，咋回事哦., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70601612109, createdName=zhouj2881, createdTime=Wed Oct 12 16:04:17 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008270, encodeId=6c3a10082e0a0, content=偏重的研究方向：肿瘤 经验分享：pending editor assignment20天了这个是找不到编辑吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6495327174, createdName=148bf9cam55暂无昵称, createdTime=Mon Aug 16 10:41:15 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589719, encodeId=5a05589e1940, content=大佬，请问接收后多久交版面费和proof？wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, beContent=wuyi1000 2019-10-13 00:00:00 发表: 2019-07-01 Submitted/Undergoing initial checking 2019-07-04 Under Review 2019-07-25 Pending Decision 2019-07-25 Major Revision 2019-08-08 Resubmitted/Undergoing initial checking 2019-08-08 Pending Decision 2019-08-12 Under Review 2019-08-29 Pending Decision 2019-08-30 Minor Revision 2019-09-01 Resubmitted/Undergoing initial checking 2019-09-03 Pending Decision 2019-09-10 Under Review 2019-09-27 Pending Decision 2019-10-08 Accept 请问各位大佬，接收后多久交版面费和proof。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ah6TsnTicIedAahqYyu4Vaz8AYx4BFqtrbafZUbkeYavADIrrBAGT3u6tn2YT6YicbtgnxwcT9sF0mCUKNcTKSiaw/132, createdBy=912e5276906, createdName=木子孑孑, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196925, encodeId=734611969258d, content=偏重的研究方向：肺癌;免疫;临床 经验分享：2021.2.17提交，3天后Awaiting AE Assignment， 2021.2.24 Pending Editor Assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07fc2427886, createdName=123ad51fm20暂无昵称, createdTime=Thu Feb 24 18:47:12 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917027, encodeId=4c0291e02704, content=这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f12441676, createdName=123d78aam27暂无昵称, createdTime=Fri Jan 15 22:32:53 CST 2021, time=2021-01-15, status=1, ipAttribution=)]

2021-01-15 123d78aam27暂无昵称

这个文章什么情况，投了半年了，还在under review。写了催稿信也不回。

109 13

展开13条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务